Mode
Text Size
Log in / Sign up

Geneticist involvement correlates with higher testing uptake and diagnostic yield in perinatal demise cases.

Geneticist involvement correlates with higher testing uptake and diagnostic yield in perinatal demis…
Photo by Ashraful Islam / Unsplash
Key Takeaway
Note that geneticist involvement correlates with higher testing uptake and diagnostic yield in perinatal demise cases.

This cohort study analyzed 111 perinatal demise cases to evaluate the impact of geneticist involvement. The primary outcomes assessed included testing uptake, diagnostic yield, and patient education. The comparator group consisted of cases without geneticist involvement. Ascertainment bias was identified as a key limitation in this observational design.

Results indicated that geneticist involvement correlated with significant increases in testing uptake, where 54% of cases received genetic testing (p=0.007). Diagnostic yield and patient education also showed significant increases (p<0.001) in cases with geneticist involvement. However, the likelihood of receiving genetic testing was decreased for cases involving second trimester stillbirths and those with fewer ultrasound abnormalities (p<0.001). Similarly, receipt of a genetics consult was less likely in cases with second trimester stillbirths (p<0.001) and fewer ultrasound abnormalities (p=0.020).

Safety and tolerability data were not reported for this study. The authors note that ascertainment bias may influence the results. Despite these limitations, the practice relevance underscores the importance of integrating genetics providers into perinatal postmortem healthcare teams. The study does not establish causality, as geneticist involvement correlates with outcomes rather than causing them.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Objective The decline of the perinatal demise rate is slowing and demises are often unexplained. Significant research has been done regarding diagnostic yield and genetic causes of demise, but little is known about how Geneticist involvement impacts outcomes. The goal of the study was to evaluate post-mortem genetic testing practices and effects of the geneticists involvement. Methods Retrospective data from 111 perinatal demise cases was examined, including rates of prenatal genetic counseling, post-delivery genetics consult, genetic testing, and autopsy investigation. Results In this cohort 54% received genetic testing and 25% received a genetics consult. When compared to those without, cases with genetic specialist involvement were associated with significant increases in testing uptake (p=0.007), diagnostic yield (p<0.001), and patient education (p<0.001). Second trimester stillbirths and those with fewer ultrasound (US) abnormalities were less likely to receive genetic testing (both p values <0.001) and consults (p<0.001, p=0.020). Conclusion Though it was not possible to avoid ascertainment bias, this data demonstrates that geneticist involvement correlates with a higher rate of testing, greater diagnostic yield, and more thorough counseling. These findings underscore the importance of integrating genetics providers into perinatal postmortem healthcare teams.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.